Pharmaceuticals Division
DVP EU grew strongly throughout the financial year. Both the existing UK and export businesses and the six months’ revenue from VetXX contributed to this performance.
Performance
- KEY PRODUCTS CONTINUE TO GROW STRONGLY
- SIGNIFICANT INCREASE IN US REVENUE
- EXCELLENT PERFORMANCE FROM DALES – OPERATING PROFIT UP 36%
Dechra Veterinary Products ("DVP")
Marketing and development of licensed branded pharmaceuticals to the veterinary profession worldwide.
Milestones
- Successful integration of VetXX
- Strong EU growth of Vetoryl and Felimazole®
- Good market penetration by new generic launches in UK
- Pharmaderm range integrated into US operation
Dales Pharmaceuticals ("Dales")
Licensed manufacturer of veterinary and human pharmaceuticals for DVP and third party customers.
Milestones
- Further new third party contracts gained
- Successful ‘go live’ on new Oracle integrated IT system
- Further progress on quality management systems